Genetic engineering of human and mouse CD4(+) and CD8(+) Tregs using lentiviral vectors encoding chimeric antigen receptors

The last decade has seen a significant increase of cell therapy protocols using effector T cells (Teffs) in particular, but also, more recently, non-engineered and expanded polyclonal regulatory T cells (Tregs) to control pathological immune responses such as cancer, autoimmune diseases, or transpla...

Descripción completa

Detalles Bibliográficos
Autores principales: Vimond, Nadège, Lasselin, Juliette, Anegon, Ignacio, Guillonneau, Carole, Bézie, Séverine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749301/
https://www.ncbi.nlm.nih.gov/pubmed/33376756
http://dx.doi.org/10.1016/j.omtm.2020.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749301/
https://www.ncbi.nlm.nih.gov/pubmed/33376756
http://dx.doi.org/10.1016/j.omtm.2020.11.008

Ejemplares similares